Next Article in Journal
Comparative Analysis of the Spectral Response to Soil Salinity of Saline-Sodic Soils under Different Surface Conditions
Previous Article in Journal
New Burnout Evaluation Model Based on the Brief Burnout Questionnaire: Psychometric Properties for Nursing
 
 
Search for Articles:
Title / Keyword
Author / Affiliation / Email
Journal
Article Type
 
 
Advanced Search
 
Section
Special Issue
Volume
Issue
Number
Page
 
Journals
IJERPH
Volume 15
Issue 12
10.3390/ijerph15122719
ijerph-logo
Submit to this Journal Review for this Journal Propose a Special Issue
► Article Menu

Article Menu

share Share announcement Help format_quote Cite question_answer Discuss in SciProfiles
first_page
settings
Order Article Reprints
Font Type:
Arial Georgia Verdana
Font Size:
Aa Aa Aa
Line Spacing:
Column Width:
Background:
Article

Influence of Active Exposure to Tobacco Smoke on Nitric Oxide Status of Pregnant Women

by
Magdalena Chełchowska
1,*,
Jadwiga Ambroszkiewicz
1,
Joanna Gajewska
1,
Joanna Mazur
2,
Leszek Lewandowski
3,
Marzanna Reśko-Zachara
4 and
Tomasz M. Maciejewski
3
1
Department of Screening and Metabolic Diagnostics, Institute of Mother and Child, 01-211 Warsaw, Poland
2
Department of Child and Adolescent Health, Institute of Mother and Child, 01-211 Warsaw, Poland
3
Department of Obstetrics and Gynaecology, Institute of Mother and Child, 01-211 Warsaw, Poland
4
Department of Neonatology and Intensive Care, Institute of Mother and Child, 01-211 Warsaw, Poland
*
Author to whom correspondence should be addressed.
Int. J. Environ. Res. Public Health 2018, 15(12), 2719; https://doi.org/10.3390/ijerph15122719
Submission received: 26 October 2018 / Revised: 14 November 2018 / Accepted: 14 November 2018 / Published: 3 December 2018
(This article belongs to the Section Environmental Health)
Browse Figures
Review Reports Versions Notes

Abstract

:
Smoking tobacco can impair proper vascular endothelial functioning. This is exhibited through reduced nitric oxide synthesis as well as activity due to accompanying oxidative stress. We examined the relationship between nitric oxide and markers of oxidative stress/antioxidant defense in serum of smoking and non-smoking pregnant women. Subjects included 99 healthy pregnant women, who were tested for nitric oxide (NO), endothelial (eNOS) and inducible (iNOS) nitric oxide synthase, total oxidant capacity (TOC), and total antioxidant capacity (TAC). NO, eNOS, and TAC serum concentrations were significantly lower (p < 0.005), but iNOS (p < 0.05) and TOC (p < 0.001) were higher in smokers than in non-smokers. Multivariate regression analysis showed associations between NO concentration and eNOS, TAC, and smoking status in the whole group of patients. In the model estimated separately for smokers, the highest impact of eNOS (β = 0.375; p = 0.021) and cotinine (β = −0.323; p = 0.037) was indicated for NO concentration. In the model of non-smokers, eNOS (β = 0.291, p = 0.030) and TAC (β = 0.350; p = 0.015) were important for NO level. Smoking during pregnancy could exacerbate oxidative stress, impair the action of nitric oxide synthases, and adversely affect the balance of oxygen and nitrogen metabolism. Relationships between NO concentrations and TAC in the studied women’s blood can confirm the antioxidant nature of nitric oxide.

1. Introduction

Smoking occupies an important place among public health problems. Poland is one of the countries where the percentage of tobacco smokers exceeds 30% of the population, including 20% of women in the reproductive period [1]. Surveys carried out at the Institute of Mother and Child in a group of 22,020 pregnant women and analysis on Polish Mother and Child Cohort conducted in a group of 1771 mothers confirmed that the percentage of women smoking during pregnancy is high and amounts to about 15–20%, and 35–50% of pregnant women are exposed to second hand smoke in the home and work environment [2,3]. Tobacco smoking is associated not only with health consequences for the mother but also with risks associated with the course of pregnancy and fetal well-being. Women who smoke during pregnancy have a higher risk of spontaneous miscarriage, ectopic pregnancy, placenta previa and premature separation, premature rupture of fetal membranes, and consequently premature birth and fetal hypotrophy. Newborns exposed to cigarette smoke in the prenatal period have a greater risk of low birth weight, decreased body length, and smaller head circumference, more frequent incidence of birth defects, as well as physical and intellectual development delays [4,5] (Table 1).
Pregnancy is characterized by intensified metabolic processes associated with the need to supply large amounts of oxygen to all the tissues and organs of the developing fetus. Reactive oxygen species (ROS) generated in both the mother and the fetus promote replication, differentiation, and maturation of the resulting cells. In the course of a normal pregnancy, increased oxidative processes connected to the intensification of lipid peroxidation and intensive production of ROS in the mitochondria, under the strict control of efficient antioxidant defense, is observed [25,26].
Smoking tobacco can significantly affect fetal growth in utero by an additional load of reactive oxygen species contained within, causing a disturbance in the oxidation-reduction balance [27,28,29,30]. It is estimated that one puff of tobacco smoke provides approx. 1015 ROS, including superoxide anion radical (O2−), hydroxyl radical (HO∙), singlet oxygen (1O2), or hydrogen peroxide (H2O2) [31].
There is a hypothesis that the harmful effects of tobacco smoke may be the result of the accumulation of oxidative endothelial cell damage. These cells synthesize endogenous nitric oxide (NO) via oxidizing L-arginine by means of nitric oxide synthases (NOS) with L-citrulline release. At least three distinct isoforms of nitric oxide synthases have been identified—two constitutive: neuronal nitric oxide synthase (nNOS, NOS1), which is primarily found in the neurons of the central and peripheral nervous system, and endothelial nitric oxide synthase (eNOS, NOS3), whose main places of expression are vascular endothelial cells, and inducible nitric oxide synthase (iNOS, NOS2), which is expressed under the influence of bacterial products, such as endotoxins and cytokines, especially in smooth muscle cells and macrophages. nNOS and eNOS are forms activated by increases in calcium concentration in the cell and the calmodulin bound by their molecules, while iNOS has such a strong affinity for the associated calmodulin that it remains active even at the lowest physiological Ca2+ concentrations. An important difference between the isoforms of the NO-synthesizing enzyme is that eNOS constantly produces moderate amounts of nitric oxide, whereas iNOS usually produces large amounts of NO [32,33,34].
The best-known role of nitric oxide during pregnancy is its participation in the regulation of uterine contractions and labor initiation. Nitric oxide diffuses into the myometrium and activates the heme part of soluble guanylyl cyclase to activate the smooth muscle soluble guanylyl cyclase, resulting in the accumulation of cyclic GMP (cGMP) in the muscle cells. This process stimulates the activity of cGMP-dependent kinases, proteins that cause muscles to relax. The appropriate NO concentrations inhibit the occurrence of contractile function and maintain the tonus of the uterine muscle at rest, being an element of the system protecting against the occurrence of contractile function in pregnancy before the date of delivery. Studies on the participation of this compound in the pathogenesis of preeclampsia, gestational diabetes mellitus, premature births, and gestational hypertension have been widely discussed [35,36,37]. However, the contribution of NO to the normal functioning of the vascular endothelium in the maternal-fetal unit, especially in situations of increased oxidative stress, has not been clearly defined. NO deficiency resulting from the disturbed expression of enzymes that catalyze its formation is thought to be associated with intrauterine growth restriction and low birth weight [33,38].
Tobacco inhaled with ROS may affect blood pressure, contributing to an imbalance between the action of vasodilating and vasoconstricting factors. Hydrogen peroxide and hydroxyl radical expand vessels, acting directly on vascular smooth muscle and stimulating NO synthesis or release; while the superoxide anion radical causes vasoconstriction, inactivating nitric oxide. The literature data describing the effect of smoking on nitric oxide levels, especially its synthases, in pregnant women are not conclusive, and relationships between NO concentration and dose and time of exposure to tobacco smoke has not been systematically investigated [38,39,40].
The aim of the study was to evaluate the effect of oxidative stress generated by smoking on the levels of nitric oxide and its synthases (inducible NOS, endothelial NOS) and their interrelations in the blood of pregnant women. To estimate the intensity of oxidative stress in the blood of the examined patients, indicators assessing Total Oxidant Capacity (TOC), Total Antioxidant Capacity (TAC), and the Oxidative Stress Index (OSI), defined as the percentage ratio of TOC to TAC level, were determined.

2. Materials and Methods

The test procedure was conducted according to the principles of the Declaration of Helsinki and was accepted by the Ethical Committee of the Institute of Mother and Child (Decision No. 14/2016). All pregnant volunteers were made aware of the study objectives and informed written consent was obtained for the analysis of the biological samples and linking results to the data collected from the questionnaires.

2.1. Subjects

The research was carried out in a group of 99 healthy pregnant women admitted for delivery at the Department of Obstetrics and Gynecology of the Institute of Mother and Child in Warsaw in 2016–2017. A total of 42 tobacco-smoking women (admitted consecutively) were included in the study group, meeting the following inclusion criteria: gestational age over 37 weeks, single pregnancy, good health, smoking a minimum of 5 cigarettes per day throughout gestation, and smoking at least 2 years before getting pregnant. Women who had obstetric and internal problems, such as gestational diabetes mellitus, hypertension, preeclampsia, premature delivery, active hepatitis, renal and cardiovascular diseases, and those who had delivery complications and prolonged labor or assisted reproduction were not included in the study. Multiple pregnancies, declared alcohol drinking, and patients on special diets, such as vegetarian or diabetic diet, were also excluded from the study. The control group consisted of 57 women selected according to the same criteria as the study group, with the exception of smoking and passive exposure to tobacco smoke (smoking family members and/or co-workers). Qualification to the groups was confirmed by determining serum cotinine concentrations, and a cut-off value of 13.7 μg/L was considered the limit between the non-smokers and the smokers, in accordance with Jarvis et al. [41]. A medical interview was conducted with all the examined women and data on the course of pregnancy and delivery were collected, and supplemented after delivery with an assessment of the newborn’s condition.
Anthropometric measurements, such as pre-pregnancy body height (m) and weight (kg), were performed and body mass index (BMI) was calculated as body weight (kg) divided by height squared (m2). Newborns were examined in the first 24 h of life. Neonatal length and weight were determined using a measuring board to the nearest 0.1 cm and a calibrated scale to the nearest 10 g.

2.2. Blood Sampling and Biochemical Analysis

The material for biochemical analysis was venous blood collected (3 mL) from patients on the day of admission for delivery while performing routine examinations. The serum obtained after centrifuging the blood (2500× g, 4 °C, 10 min) was stored in small portions until the analysis was performed (−70 °C, less than 2 months).
Concentrations of nitric oxide, nitric oxide synthase eNOS and iNOS, and cotinine in serum were determined by immunoenzymatic methods (ELISA) using monoclonal antibodies. Nitric oxide level was evaluated using Human (NO) ELISA kit (SunRed; Shanghai, China). Levels of eNOS and iNOS were determined using the Human NOS3 ELISA and Human NOS2 ELISA sets, respectively (Cloud-Clone Corp., Houston, TX, USA). The manufacturer’s data on intra- and inter-assay coefficients of variation (CV) were less than 8.0% and 11.0% for NO, 10.0% and 12.0% for NOS, respectively. Cotinine concentration was measured using a commercially available kit, Cotinine Direct ELISA (Calbiotech Inc., Spring Valley, CA, USA). The intra- and inter-assay CV for this method were less than 10%.
Total oxidant capacity and total antioxidant capacity values were measured by colorimetric assay based on the enzymatic reaction of peroxides and peroxidases according to Tatzber et al. [42] (Labor Diagnostica Nord GmbH&Co.KG, Nordhorn, Germany). The manufacturer’s data on intra- and inter-assay coefficients of variation were less than 4.9% and 7.33% for TOC, 2.5% and 3.33% for TAC, respectively. OSI was calculated from the measured values of TOC and TAC using the TOC/TAC ratio multiplied by 100 [43,44].

2.3. Statistical Analysis

The statistical analyses of the results were performed using SPSS statistical software version 17.1 (SPSS INC., Chicago, IL, USA). Normality of variables was tested using the Kolmogorov–Smirnov test. The symmetrically distributed data were presented as means with standard deviation (SD) and the asymmetrically distributed data as medians with interquartile range (25–75th percentiles). The baseline characteristics and biochemical parameters were compared using the Student t-test or Mann–Whitney U test, depending on the assumptions. The Chi-squared test was used for comparing nominal variables. Correlation analysis was performed based on Pearson or Spearman coefficients, adequately to the distribution of variables. The potential influence of oxidative stress markers on the level of nitric oxide was estimated by linear regression analysis. Results were presented as the value of B unstandardized regression coefficient with 95% confidence interval and change in R-squared coefficient after each variable was entered. Models were estimated separately for smokers and non-smokers as well as for the total group. A p value of <0.05 was considered statistically significant.

3. Results

Pregnant women in both groups were of similar age (28.5 ± 4.5 years vs. 29.8 ± 4.2 years; p = 0.091, smokers and non-smokers, respectively) and did not differ in terms of gestational age (39.1 ± 1.1 weeks of pregnancy vs. 39.5 ± 1.0 weeks of pregnancy, p = 0.055, smokers and non-smokers, respectively). The patients’ anthropometric parameters were similar in the study and the control groups (height: 163.8 ± 4.4 cm vs. 165.5 ± 4.6 cm, p = 0.075; weight: 63.7 ± 5.5 kg vs. 65.3 ± 6.1 kg, p = 0.187; BMI: 23.7 ± 1.6 vs. 23.8, p = 0.804, respectively). In the group of smokers, the median value of number of cigarettes smoked per day was 8 (mean: 8.86 ± 4.29; range: 5–20), and the median of duration of the habit before conception was 8 years (mean: 8.26 ± 3.39; range: 2–15). In this group, blood cotinine levels ranged from 51.4 μg/L to 107.2 μg/L, while in the tobacco abstinent group cotinine was found in only two cases in trace amounts (0.0 μg/L to 2.1 μg/L). The newborns of actively smoking mothers did not differ in terms of sex and Apgar score from the newborns of non-smokers (42.9% girls, 57.1% boys, 10 points vs. 43.9% girls, 56.1% boys, 10 points, p = 0.543, respectively). The birth weight and length of the children of smokers was significantly lower than those of non-smokers (3088 ± 407 g vs. 3521 ± 397 g, 53.9 ± 2.5 cm vs. 56.0 ± 2.5 cm, respectively, p ≤ 0.001).
NO, eNOS, and TAC concentrations in the serum of smokers were significantly lower than those observed in the tobacco abstinent group. In addition, iNOS, TOC, and oxidative stress index values were significantly higher than in the group of non-smokers (Table 2). In smokers, the nitric oxide level was negatively correlated with the number of cigarettes smoked per day and cotinine concentration (r = −0.516, p ≤ 0.001). A similar relationship occurred between eNOS level and cotinine concentration (r = −0.334, p = 0.031) while the correlation of eNOS with the number of cigarettes smoked per day was on the border of statistical significance (r = −0.294, p = 0.059). We found no significant relationships between iNOS level and the studied parameters describing smoking intensity.
Based on regression analysis, a positive correlation between NO concentration and eNOS level and a negative relationship between NO and iNOS concentrations was found in the whole group of patients. Close correlations between nitric oxide and endothelial form of nitric oxide synthase were confirmed in both the study and the control groups (Table 3).
Table 4 and Figure 1, Figure 2, Figure 3, Figure 4 and Figure 5 present relations between the studied nitric oxide parameters and oxidative stress markers separately for the smokers and the non-smokers groups. There was a significant positive relationship between NO and TAC in both studied groups, while an inverse association between NO and TOC was found only in the smoking group (Figure 1 and Figure 2).
Serum concentration of NO slightly correlated negatively with the OSI value in smoking and non-smoking mothers, but it was on the border of statistical significance (Figure 3).
The level of serum eNOS correlated positively with TAC in the non-smoking group and negatively with TOC in the smoking group (Figure 4 and Figure 5).
There was no significant association between eNOS and OSI in both studied groups (Table 3). Positive associations between iNOS concentrations and TOC as well as OSI values in the group of smoking mothers were found. We did not observe connections between iNOS and TAC levels in any of the studied groups (Table 4).
In the multivariate regression model (adjusted for age, gestational age, BMI), we observed associations between nitric oxide concentration and eNOS, TAC, and smoking status in the whole group of pregnant women (Table 5).
In the model estimated separately for smokers, the highest impact of the serum eNOS and concentration of cotinine was indicated for NO concentration. In the model of non-smokers, eNOS and TAC were of significant importance for the nitric oxide level. R-squared (expressed as percentage of a variation that can be explained by a linear regression model) was 54.1 for the whole group of women, 45.2 for the smokers group, and 32.7 for the tobacco abstinent group.

4. Discussion

In the presented study, we found significant correlations between serum concentration of nitric oxide and its synthases, and oxidative stress markers in pregnant women. We also confirmed a negative effect of tobacco smoking on the studied biochemical parameters.
It is widely known that smoking intensifies free radical generation processes, often coexisting with an insufficiency of antioxidant systems, manifested by a decline in the concentrations of individual antioxidants and damage to the endothelium of blood vessels [30,45,46]. This results in impaired synthesis of endogenous nitric oxide, which in turn can lead to dangerous thickening and stiffening of blood vessel walls. An imbalance between the action of vasodilating and vasoconstricting factors may be the result of a loss of diastolic capacity dependent on nitric oxide, as well as a reduction in NO production or availability in both uteroplacental and fetal-placental circulation. Trophoblast-derived nitric oxide may prevent the adhesion and aggregation of platelets and leukocytes in syncytiotrophoblasts, maintaining proper circulation in the intervillous space [33,38,45,47].
The presented study shows that smoking tobacco significantly reduces nitric oxide levels in the blood serum of pregnant women, which is consistent with our previous reports [40] and the results obtained by other authors [31,38,39]. Similarly to the study by Node et al. [48], the level of this compound was dependent on the amount of cigarettes smoked. The close positive correlation between NO and total antioxidant capacity we observed in both groups may confirm the antioxidative nature of this compound suggested by other authors [32,49]. Negative correlations between NO and total oxidant capacity in the blood of smoking women coexisting with lower TAC levels in this group seem to explain the influence of oxidative stress caused by smoking on nitric oxide concentration. This may be due to disturbed expression and the associated reduction in the amount of the eNOS form. It was shown that ROS from tobacco smoke induced eNOS uncoupling secondary by reducing the concentration of tetrahydrobiopterin (BH4), which is an important cofactor for the production of NO with NOS susceptible to oxidative stress [32]. People who smoke also have disorders related to the cyclooxygenase (COX) pathway, which might be involved in NO homeostasis disturbances [50,51]. An in vitro study shown that an increase in intracellular O2 levels observed in histone-treated HUVEC, at least in part produced by COX-2 activity, contributes to decreased eNOS expression and NO bioavailability [52].
There are few data in the literature describing the effect of smoking on nitric oxide synthase concentrations in pregnant women. The study by Andersen et al. [33,38] indicates that eNOS activity and concentration in umbilical cord endothelial cells were significantly lower in the children of smokers than children of non-smokers. As a result of multivariate regression analysis, these authors found that a 20% reduction in eNOS activity, associated with smoking, may be due to reduced eNOS concentrations, and 5% due to reduced HDL concentrations [38]. It is known that tobacco smoking disturbs the lipid profile in pregnant women, who have higher levels of LDL and lower HDL than non-smokers, which predisposes this group to oxidative lipid damage and subsequent damage to cell membranes, including endothelial cells [28,53].
In our study, eNOS concentrations in the serum of smoking pregnant women were lower than in the tobacco abstinent group. In addition, nitric oxide levels were strictly dependent on endothelial nitric oxide synthase levels in both studied groups. This may be the result of lower estrogen and L-arginine levels in smokers, which leads to a rise in asymmetric dimethylarginine (ADMA), an inhibitor of nitric oxide synthase [54,55]. A decrease of about 30% in estriol after 37 weeks of pregnancy has been observed in women smokers, which can directly affect endothelial NO synthase concentration and nitric oxide bioavailability [33].
The effect of oxidative disturbances on estrogen levels and eNOS regulation has been observed in both animal and human studies [56,57,58]. Novella et al. [59] found that oxLDL increased ADMA levels in human arterial endothelial cells. The authors suggest that estradiol may protect cells from oxLDL-induced damage. This could involve a decline in ADMA levels and an enhancement of NO release. It is known that oxidative stress contributes to endothelial dysfunction in estrogen-deficient postmenopausal women. An in vitro study conducted in mice with experimental menopause shown that the interaction between NOS and COX pathways is altered by aging as well as estrogen status and is driven partially by COX-mediated generation of superoxide (O2−), which deceases NO bioavailability [60]. The negative correlations we observed between eNOS and cotinine and TOC seem to confirm the involvement of oxidative stress in the formation and activity of this enzyme in pregnant women who smoke tobacco.
The nicotine contained in tobacco smoke affects the endothelium, leading not only to permanent damage but also to reducing nitric oxide synthesis. In vivo studies showed that local exposure to nicotine is associated with a decreased response to bradykinin in human vasculature, suggesting that vasoconstriction may be the result of inhibited eNOS activity [61]. The hypoxia resulting from the action of carbon monoxide also lowers both eNOS activity and concentration in human umbilical cord endothelial cells compared with conditions with normal oxidation status [62].
The increase in reactive oxygen species (ROS) production observed in smoking pregnant women and the reduced possibility of their inactivation by antioxidant mechanisms may reduce NO synthesis and decrease NO availability [27,29,63]. It is highly probable that higher inducible nitric oxide synthase activity and concentration results from ROS generation by tobacco smoke. In our studies, iNOS level was significantly higher in women smokers compared with non-smokers and was positively correlated with OSI and TOC levels in the blood. This is concordant with the results of other studies conducted in animals and in human epithelial endometrial cell cultures [34]. In vitro experiments showed that exogenous nitric oxide may increase iNOS expression in macrophages stimulated by interferon gamma and lipopolysaccharides [49]. Chronic inflammation, often accompanying smoking, may be a source of pro-inflammatory cytokines and thus induce iNOS expression [53,64].
Due to NO presence in tobacco smoke (about 500 ppm of NO and other active nitrogen oxides), it was expected that as a result of smoking, the NO metabolites in systemic circulation will increase [65]. Animal studies suggest that inhalation of tobacco smoke causes an increase in NO concentration in the plasma, which is probably the result of the release of exogenous NO from tobacco smoke. In the animal model, exposure to tobacco smoke was much higher than the average tobacco smoker is exposed to, which may explain the high levels of this compound found in the examined animals [66]. Chambers et al. [67] showed a temporary increase in NO concentrations in smokers. However, it seems that the temporary increase in NO concentration results from the inhalation of exogenous NO contained in smoke and refers only to the respiratory tract of active smokers. It can also be assumed that the long-term reduction in eNOS activity in people who are actively smoking has a greater influence on the status of endogenous NO in these people than transient exposure to exogenous NO from tobacco smoke.
An important limitation of the present study was the small sample size; however, the studied group was homogeneous. All women were similar in age, age of gestation, and type of delivery, which are recognized as important factors for nitric oxide and oxidative stress marker levels [68]. Another limitation is that we did not use a typical study design for a case-control study with retrospective assumptions, and a prospective comparison of vulnerable groups and those not exposed to one factor, in this case tobacco smoking. Although the recruitment method used did not allow reaching the percentage of smokers representing a normal pregnant population, we managed to compare groups that did not differ in size or basic characteristics [69]. We lacked data on inflammatory marker concentrations (except for CRP) in the studied patients, but all women were healthy without inflammation processes confirmed by negative C-reactive protein. Also, we did not have data on estrogen levels, but it was clear from the medical history that no patient received estrogen treatment during pregnancy. There were no complications in the course of pregnancy, and all births were through natural passage at full term. Although it is known that smoking markedly affects antioxidant estrogen status, determining the relations between them and oxidative stress markers generated by smoking in pregnancy should be continued [57,58].
The presented results can be used to establish rational supplementation with preparations containing antioxidants for the prevention of oxidative/antioxidant balance disorders and as a consequence of free radical damage and related complications.
In summary, the obtained results indicate that smoking during pregnancy could exacerbate oxidative stress, impair the action of nitric oxide synthases, and adversely affect the balance of oxygen and nitrogen metabolism. Relationships between NO concentrations and total antioxidant capacity in the studied women’s blood can confirm the antioxidant nature of nitric oxide.

Author Contributions

M.C., J.A., J.G. performed biochemical measurements and analyzed the data. J.M. performed the statistical analysis and the interpretation of data. L.L., M.R.-Z. participated in data collection and checked the clinical data. M.C. conducted the organization of the study and drafted the manuscript. T.M.M. conducted the clinical data analysis and revised the manuscript. All of the authors were involved in writing the paper and approved the final version.

Funding

This research received no external funding.

Conflicts of Interest

The authors declare no conflict of interest.

References

  1. Polakowska, M.; Kaleta, D.; Piotrowski, W.; Topór-Mądry, R.; Puch-Walczak, A.; Niklas, A.; Bielecki, W.; Kozakiewicz, K.; Pająk, A.; Tykarski, A.; et al. Tobacco smoking in Poland in the years from 2003 to 2014. Multi-centre National Population Health Examination Survey (WOBASZ). Pol. Arch. Inter. Med. 2017, 127, 91–99. [Google Scholar] [CrossRef]
  2. Laskowska-Klita, T.; Chełchowska, M.; Ołtarzewski, M.; Gajewska, J.; Ambroszkiewicz, J. The effect of tobacco smoking during pregnancy on birth mass on the basis of population study—Preliminary results. Prz. Lek. 2010, 67, 830–834. [Google Scholar] [PubMed]
  3. Polanska, K.; Krol, A.; Kaluzny, P.; Ligocka, D.; Mikolajewska, K.; Shaheen, S.; Walton, R.; Hanke, W. Estimation of cut-off points for active and passive smoking during pregnancy-polish mother and child cohort (REPRO_PL). Int. J. Environ. Res. Public Health 2016, 13, 1216. [Google Scholar] [CrossRef] [PubMed]
  4. Król, M.; Florek, E.; Piekoszewski, W.; Bokiniec, R.; Kornacka, M.K. The impact of intrauterine tobacco exposure on the cerebral mass of the neonate based on the measurement of head circumference. Brain Behav. 2012, 2, 243–248. [Google Scholar] [CrossRef] [PubMed] [Green Version]
  5. Kharkova, O.A.; Grjibovski, A.M.; Krettek, A.; Nieboer, E.; Odland, J.O. Effect of smoking behawior before and during pregnancy on selected birth outcomes among singleton full-term pregnancy: A Murmansk County Birth Registry Study. Int. J. Environ. Res. Public Health 2017, 14, 867. [Google Scholar] [CrossRef] [PubMed]
  6. Pereira, P.P.; Da Mata, F.A.; Figueiredo, A.C.; de Andrade, K.R.; Pereira, M.G. Maternal active smoking during pregnancy and low birth weight in the Americas: A systematic review and meta-analysis. Nicotine Tob. Res. 2017, 19, 497–505. [Google Scholar] [CrossRef] [PubMed]
  7. Dietz, P.M.; England, L.J.; Shapiro-Mendoza, C.K.; Tong, V.T.; Farr, S.L.; Callaghan, W.M. Infant morbidity and mortality attributable to prenatal smoking in the U.S. Am. J. Prev. Med. 2010, 39, 45–52. [Google Scholar] [CrossRef]
  8. Wisborg, K.; Kesmodel, U.; Henriksen, T.B.; Olsen, S.F.; Secher, N.J. Exposure to tobacco smoke in utero and the risk of stillbirth and death in the first year of life. Am. J. Epidemiol. 2001, 154, 322–327. [Google Scholar] [CrossRef]
  9. Leite, M.; Albieri, V.; Kjaer, S.K.; Jensen, A. Maternal smoking in pregnancy and risk for congenital malformations: results of a Danish register-based cohort study. Acta Obstet. Gynecol. Scand. 2014, 93, 825–834. [Google Scholar] [CrossRef]
  10. Mennella, J.A.; Yourshaw, L.M.; Morgan, L.K. Breastfeeding and smoking: short-term effects on infant feeding and sleep. Pediatrics 2007, 120, 497–502. [Google Scholar] [CrossRef]
  11. Talati, A.; Wickramaratne, P.J.; Wesselhoeft, R.; Weissman, M.M. Prenatal tobacco exposure, birthweight, and offspring psychopathology. Psychiatry Res. 2017, 252, 346–352. [Google Scholar] [CrossRef] [PubMed]
  12. Polanska, K.; Krol, A.; Merecz-Kot, D.; Ligocka, D.; Mikolajewska, K.; Mirabella, F.; Chiarotti, F.; Calamandrei, G.; Hanke, W. Environmental Tobacco Smoke Exposure during Pregnancy and Child Neurodevelopment. Int. J. Environ. Res. Public Health 2017, 14, 796. [Google Scholar] [CrossRef] [PubMed]
  13. Albers, L.; Sobotzki, C.; Kuß, O.; Ajslev, T.; Batista, R.; Bettiol, H.; Brabin, B.; Buka, S.L.; Cardoso, V.C.; Clifton, V.L. Maternal smoking during pregnancy and offspring overweight: is there a dose-response relationship? An individual patient data meta-analysis. Int. J. Obes. (Lond). 2018, 42, 1249–1264. [Google Scholar] [CrossRef] [PubMed]
  14. Burke, H.; Leonardi-Bee, J.; Hashim, A.; Pine-Abata, H.; Chen, Y.; Cook, D.G.; Britton, J.R.; McKeever, T.M. Prenatal and passive smoke exposure and incidence of asthma and wheeze: systematic review and meta-analysis. Pediatrics 2012, 129, 735–744. [Google Scholar] [CrossRef] [PubMed]
  15. Brion, M.J.; Leary, S.D.; Lawlor, D.A.; Smith, G.D.; Ness, A.R. Modifiable maternal exposures and offspring blood pressure: a review of epidemiological studies of maternal age, diet, and smoking. Pediatr. Res. 2008, 63, 593–598. [Google Scholar] [CrossRef]
  16. Bao, W.; Michels, K.B.; Tobias, D.K.; Li, S.; Chavarro, J.E.; Gaskins, A.J.; Vaag, A.A.; Hu, F.B.; Zhang, C. Parental smoking during pregnancy and the risk of gestational diabetes in the daughter. Int. J. Epidemiol. 2016, 45, 160–169. [Google Scholar] [CrossRef] [Green Version]
  17. England, M.C.; Benjamin, A.; Abenhaim, H.A. Increased risk of preterm premature rupture of membranes at early gestational ages among maternal cigarette smokers. Am. J. Perinatol. 2013, 30, 821–826. [Google Scholar] [CrossRef]
  18. Shobeiri, F.; Jenabi, E. Smoking and placenta previa: a meta-analysis. J. Matern. Fetal. Neonatal. Med. 2017, 30, 2985–2990. [Google Scholar] [CrossRef]
  19. Nio-Kobayashi, J.; Abidin, H.B.; Brown, J.K.; Iwanaga, T.; Horne, A.W.; Duncan, W.C. Cigarette smoking alters sialylation in the Fallopian tube of women, with implications for the pathogenesis of ectopic pregnancy. Mol. Reprod. Dev. 2016, 83, 1083–1091. [Google Scholar] [CrossRef] [Green Version]
  20. Pineles, B.L.; Park, E.; Samet, J.M. Systematic review and meta-analysis of miscarriage and maternal exposure to tobacco smoke during pregnancy. Am. J. Epidemiol. 2014, 179, 807–823. [Google Scholar] [CrossRef]
  21. Ko, T.J.; Tsai, L.Y.; Chu, L.C.; Yeh, S.J.; Leung, C.; Chen, C.Y.; Chou, H.C.; Tsao, P.N.; Chen, P.C.; Hsieh, W.S. Parental smoking during pregnancy and its association with low birth weight, small for gestational age, and preterm birth offspring: a birth cohort study. Pediatr. Neonatol. 2014, 55, 20–27. [Google Scholar] [CrossRef] [PubMed]
  22. Ion, R.; Bernal, A.L. Smoking and Preterm Birth. Reprod. Sci. 2015, 22, 918–926. [Google Scholar] [CrossRef] [PubMed]
  23. Blatt, K.; Moore, E.; Chen, A.; Van Hook, J.; DeFranco, E.A. Association of reported trimester-specific smoking cessation with fetal growth restriction. Obstet. Gynecol. 2015, 125, 1452–1459. [Google Scholar] [CrossRef] [PubMed]
  24. Abraham, M.; Alramadhan, S.; Iniguez, C.; Duijts, L.; Jaddoe, V.W.; Den Dekker, H.T.; Crozier, S.; Godfrey, K.M.; Hindmarsh, P.; Vik, T. A systematic review of maternal smoking during pregnancy and fetal measurements with meta-analysis. PLoS ONE 2017, 12, e0170946. [Google Scholar] [CrossRef] [PubMed]
  25. Ardalic, D.; Stefanovic, A.; Kotur-Stevuljevic, J.; Vujović, A.; Spasić, S.; Spasojević-Kaliomanvska, V.; Jelić-Ivanović, Z.; Mandić-Marković, V.; Miković, Z.; Cerović, N. The influence of maternal smoking habits before pregnancy and antioxidative supplementation during pregnancy on oxidative stress status in non-complicated pregnancy. Adv. Clin. Exp. Med. 2014, 23, 575. [Google Scholar] [CrossRef] [PubMed]
  26. Al-Gubory, K.H.; Fowler, P.A.; Garrel, C. The roles of cellular reactive oxygen species, oxidative stress and antioxidants in pregnancy outcomes. Int. J. Biochem. Cell Biol. 2010, 42, 1634–1650. [Google Scholar] [CrossRef] [PubMed]
  27. Gromadzińska, J.; Polanska, K.; Kozlowska, L.; Mikolajewska, K.; Stelmach, I.; Jerzynska, J.; Stelmach, W.; Grzesiak, M.; Hanke, W.; Wasowicz, W. Vitamins A and E during pregnancy and allergy symptoms in an early childhood-lack of association with tobacco smoke exposure. Int. J. Environ. Res. Public Health 2018, 15, 1245. [Google Scholar] [CrossRef]
  28. Bizoń, A.; Milnerowicz, H. The effect of passive and active exposure to tobacco smoke on lipid profile parameters and the activity of certain membrane enzymes in the blood of women in the first trimester of pregnancy. Environ. Toxicol. Pharmacol. 2017, 53, 74–80. [Google Scholar] [CrossRef]
  29. Chełchowska, M.; Ambroszkiewicz, J.; Gajewska, J.; Laskowska-Klita, T.; Leibschang, J. The effect of tobacco smoking during pregnancy on plasma oxidant and antioxidant status in mother and newborn. Eur. J. Obstet. Gynecol. Reprod. Biol. 2011, 155, 132–136. [Google Scholar] [CrossRef]
  30. Orhon, F.S.; Ulukol, B.; Kahya, D.; Cengiz, B.; Baskan, S.; Tezcan, S. The influence of maternal smoking on maternal and newborn oxidant and antioxidant status. Eur. J. Pediatr. 2009, 168, 975–981. [Google Scholar] [CrossRef]
  31. Valavanidis, A.; Vlachogianni, T.; Fiotakis, K. Tobacco smoke: Involvement of reactive oxygen species and stable free radicals in mechanisms of oxidative damage, carcinogenesis and synergistic effects with other respirable particles. Int. J. Environ. Res. Public Health 2009, 6, 445–462. [Google Scholar] [CrossRef] [PubMed]
  32. Abdelghany, T.M.; Ismail, R.S.; Mansoor, F.A.; Zweier, J.R.; Lowe, F.; Zweier, J.L. Cigarette smoke constituents cause endothelial nitric oxide synthase dysfunction and uncoupling due to depletion of tetrahydrobiopterin with degradation of GTP cyclohydrolase. Nitric Oxide 2018, 76, 113–121. [Google Scholar] [CrossRef] [PubMed]
  33. Andersen, M.R.; Walker, L.R.; Stender, S. Reduced endothelial nitric oxide synthase activity and concentration in fetal umbilical veins from maternal cigarette smokers. Am. J. Obstet. Gynecol. 2004, 191, 346–351. [Google Scholar] [CrossRef] [PubMed]
  34. Khorram, O.; Han, G.; Magee, T. Cigarette smoke inhibits endometrial epithelial cell proliferation through a nitric oxide-mediated pathway. Fertil. Steril. 2010, 93, 257–263. [Google Scholar] [CrossRef] [PubMed]
  35. Mordwinkin, N.M.; Ouzounian, J.G.; Yedigarova, L.; Montoro, M.N.; Louie, S.G.; Rodgers, K.E. Alteration of endothelial function markers in women with gestational diabetes and their fetuses. J. Matern. Fetal Neonatal Med. 2013, 26, 507–512. [Google Scholar] [CrossRef] [PubMed]
  36. Shaamash, A.H.; Elsnosy, E.D.; Makhlouf, A.M.; Zakhari, M.M.; Ibrahim, O.A.; EL-dien, H.M. Maternal and fetal serum nitric oxide (NO) concentrations in normal pregnancy, pre-eclampsia and eclampsia. Int. J. Gynecol. Obstet. 2000, 68, 207–214. [Google Scholar] [CrossRef]
  37. Hodžić, J.; Izetbegović, S.; Muračević, B.; Iriškić, R.; Jović, H.Š. Nitric oxide biosynthesis during normal pregnancy and pregnancy complicated by preeclampsia. Med. Glas. (Zenica) 2017, 14, 211. [Google Scholar] [CrossRef]
  38. Andersen, M.R.; Simonsen, U.; Uldbjerg, N.; Aalkjaer, C.; Stender, S. Smoking cessation early in pregnancy and birth weight, length, head circumference, and endothelial nitric oxide synthase activity in umbilical and chorionic vessels. Circulation 2009, 119, 857–864. [Google Scholar] [CrossRef]
  39. Ozerol, E.; Ozerol, I.; Gokdeniz, R.; Temel, I.; Akyol, O. Effect of smoking on serum concentrations of total homocysteine, folate, vitamin B12, and nitric oxide in pregnancy: A preliminary study. Fetal Diagn. Ther. 2004, 19, 145–148. [Google Scholar] [CrossRef]
  40. Chełchowska, M.; Maciejewski, T.; Ambroszkiewicz, J.; Gajewska, J.; Łecka, R.; Laskowska-Klita, T.; Ołtarzewski, M. The effect of tobacco smoking on nitric oxide serum concentration in pregnant women and umbilical cord blood. Prz. Lek. 2009, 66, 648–651. [Google Scholar]
  41. Jarvis, M.J.; Tunstall-Pedoe, H.; Feyerabend, C.; Vesey, C.; Saloojee, Y. Comparison of tests used to distinguish smokers from non-smokers. Am. J. Public Health 1987, 77, 1435–1438. [Google Scholar] [CrossRef] [PubMed]
  42. Tatzber, F.; Griebenow, S.; Wonisch, W.; Winkler, R. Dual method for the determination of peroxidase activity and total peroxides-iodide leads to a significant increase of peroxidase activity in human sera. Anal. Biochem. 2003, 316, 147–153. [Google Scholar] [CrossRef]
  43. Ozler, A.; Ucmak, D.; Evsen, M.S.; Kaplan, I.; Elbey, B.; Arica, M.; Kaya, M. Immune mechanisms and the role of oxidative stress in intrahepatic cholestasis of pregnancy. Cent. Eur. J. Immunol. 2014, 39, 198–202. [Google Scholar] [CrossRef] [PubMed]
  44. Maciejczyk, M.; Szulimowska, J.; Skutnik, A.; Taranta-Janusz, K.; Wasilewska, A.; Wiśniewska, N.; Zalewska, A. Salivary Biomarkers of Oxidative Stress in Children with Chronic Kidney Disease. J. Clin. Med. 2018, 7, 209. [Google Scholar] [CrossRef] [PubMed]
  45. Barua, R.S.; Ambrose, J.A.; Srivastava, S.; DeVoe, M.C.; Eales-Reynolds, L.J. Reactive oxygen species are involved in smoking-induced dysfunction of nitric oxide biosynthesis and upregulation of endothelial nitric oxide synthase: An in vitro demonstration in human coronary artery endothelial cells. Circulation 2003, 107, 2342–2347. [Google Scholar] [CrossRef] [PubMed]
  46. Milnerowicz-Nabzdyk, E.; Bizoń, A. Effect of cigarette smoking on vascular flows in pregnancies complicated by intrauterine growth restriction. Reprod. Toxicol. 2014, 50, 27–35. [Google Scholar] [CrossRef] [PubMed]
  47. Zdravkovic, T.; Genbacev, O.; McMaster, M.T.; Fisher, S.J. The adverse effects of maternal smoking on the human placenta: A review. Placenta 2005, 26A, 81–90. [Google Scholar] [CrossRef] [PubMed]
  48. Node, K.; Kitakaze, M.; Yashikawa, H.; Kosaka, H.; Hori, M. Reversible reduction in plasma concentration of nitric oxide induced by cigarette smoking in young adults. Am. J. Cardiol. 1997, 79, 1538–1541. [Google Scholar] [CrossRef]
  49. Stępnik, M. Molecular aspects of toxic effects of nitric oxide. Med. Pr. 2001, 52, 375–381. [Google Scholar]
  50. Shi, Z.; Chen, Y.; Pei, Y.; Liu, C.; Cao, J.; Chen, P. The role of cyclooxygenase-2 in the protection against apoptosis in vascular endothelial cells induced by cigarette smoking. J. Thorac. Dis. 2017, 9, 30. [Google Scholar] [CrossRef]
  51. Loke, W.M.; Sing, K.L.; Lee, C.Y.; Chong, W.L.; Chew, S.E.; Huang, H.; Looi, W.F.; Quek, A.M.; Lim, E.C.; Seet, R.C. Cyclooxygenase-1 mediated platelet reactivity in young male smokers. Clin. Appl. Thromb. Hemost. 2014, 20, 371–377. [Google Scholar] [CrossRef] [PubMed]
  52. Pérez-Cremades, D.; Bueno-Betí, C.; García-Giménez, J.L.; Ibañez-Cabellos, J.S.; Hermenegildo, C.; Pallardó, F.V.; Novella, S. Extracellular histones disarrange vasoactive mediators release through a COX-NOS interaction in human endothelial cells. J. Cell. Mol. Med. 2017, 21, 1584–1592. [Google Scholar] [CrossRef] [PubMed] [Green Version]
  53. Attard, R.; Dingli, P.; Doggen, C.J.M.; Cassar, K.; Farrugia, R.; Wettinger, S.B. The impact of passive and active smoking on inflammation, lipid profile and the risk of myocardial infarction. Open Heart 2017, 4, e000620. [Google Scholar] [CrossRef] [PubMed]
  54. Laskowska, M.; Laskowska, K.; Oleszczuk, J. Maternal serum levels of endothelial nitric oxide synthase and ADMA, endogenous eNOS inhibitor in pregnancies complicated by severe preeclampsia. Pregnancy Hypertens. 2012, 2, 312. [Google Scholar] [CrossRef] [PubMed]
  55. Ulm, M.R.; Plockinger, B.; Pirich, C.; Gryglewski, R.J.; Sinzinger, H.F. Umbilical arteries of babies born to cigarette smokers generate less prostacyclin and contain less arginine and citruline compared with those of babies born to control subjects. Am. J. Obstet. Gynecol. 1995, 172, 1485–1487. [Google Scholar] [CrossRef]
  56. Dobrzycka, B.; Kinalski, M.; Piechocka, D.; Terlikowski, S.J. The role of estrogens in angiogenesis in the female reproductive system. Endokrynol. Pol. 2009, 60, 210–214. [Google Scholar] [PubMed]
  57. Szkup, M.; Jurczak, A.; Karakiewicz, B.; Kotwas, A.; Kopeć, J.; Grochans, E. Influence of cigarette smoking on hormone and lipid metabolism in women in late reproductive stage. Clin. Interv. Aging 2018, 13, 109. [Google Scholar] [CrossRef]
  58. Marom-Haham, L.; Shulman, A. Cigarette smoking and hormones. Curr. Opin. Obstet. Gynecol. 2016, 28, 230–235. [Google Scholar] [CrossRef]
  59. Novella, S.; Laguna-Fernández, A.; Lázaro-Franco, M.; Sobrino, A.; Bueno-Betí, C.; Tarín, J.J.; Monsalve, E.; Sanchís, J.; Hermenegildo, C. Estradiol, acting through estrogen receptor alpha, restores dimethylarginine dimethylaminohydrolase activity and nitric oxide production in oxLDL-treated human arterial endothelial cells. Mol. Cell. Endocrinol. 2013, 365, 11–16. [Google Scholar] [CrossRef] [Green Version]
  60. Vidal-Gómez, X.; Novella, S.; Pérez-Monzó, I.; Garabito, M.; Dantas, A.P.; Segarra, G.; Hermenegildo, C.; Medina, P. Decreased bioavailability of nitric oxide in aorta from ovariectomized senescent mice. Role of cyclooxygenase. Exp. Gerontol. 2016, 76, 1–8. [Google Scholar] [CrossRef]
  61. Chalon, S.; Moreno, H.; Benowitz, N.L.; Hoffmann, B.B.; Blaschke, T.F. Nicotine impairs endothelium-dependent dilatation in human veins in vivo. Clin. Pharmacol. Ther. 2000, 67, 391–397. [Google Scholar] [CrossRef] [PubMed]
  62. Ostergaard, L.; Stankevicius, E.; Andersen, M.R.; Eskildsen-Helmond, Y.; Ledet, T.; Mulvany, M.J.; Simonsen, U. Diminished NO release in chronic hypoxic endothelial cells. Am. J. Physiol. Heart Circ. Physiol. 2007, 293, H2894–H2903. [Google Scholar] [CrossRef] [PubMed]
  63. Tsuchiya, M.; Asada, A.; Kasahara, E.; Sato, E.F.; Shindo, M.; Inoue, M. Smoking a single cigarette rapidly reduces combined concentrations of nitrate and nitrite and concentrations of antioxidants in plasma. Circulation 2002, 105, 1155–1157. [Google Scholar] [CrossRef] [PubMed]
  64. Chahal, N.; McLain, A.C.; Ghassabian, A.; Michels, K.A.; Bell, E.M.; Lawrence, D.A.; Yeung, E.H. Maternal smoking and newborn cytokine and immunoglobulin levels. Nicotine Tob. Res. 2017, 19, 789–796. [Google Scholar] [CrossRef]
  65. Billert, H. Tobacco use disorder and nitric oxide metabolism—Pathomechanisms of the perioperative cardiovascular and respiratory complications in the perioperative period. Prz. Lek. 2011, 68, 1017–1020. [Google Scholar]
  66. Nene, S.; Gelabert, H.; Moore, W.; Quinones-Baldrich, W.; Santibanez-Gallerani, A.; Ignarro, L. Cigarette smoking increases endothelial-derived vasorelaxation in the rat carotid artery in a dose-dependent manner. J. Surg. Res. 1997, 71, 101–106. [Google Scholar] [CrossRef] [PubMed]
  67. Chambers, D.C.; Tunnicliffe, W.S.; Ayres, J.G. Acute inhalation of cigarette smoke increases lower respiratory tract nitric oxide concentrations. Thorax 1998, 53, 677–679. [Google Scholar] [CrossRef] [PubMed] [Green Version]
  68. Ghasemi, A.; Zahedi Asl, S.; Mehrabi, Y.; Saadat, N.; Azizi, F. Serum nitric oxide metabolite levels in a general healthy population: Relation to sex and age. Life Sci. 2008, 83, 326–331. [Google Scholar] [CrossRef]
  69. Marshall, T. What is a case-control study? Int. J. Epidemiol. 2004, 33, 612–613. [Google Scholar] [CrossRef] [Green Version]
Ijerph 15 02719 g001 550
Figure 1. Correlations between serum NO and TAC levels in the subgroups of smoking (n = 42) and non-smoking pregnant women (n = 57).
Figure 1. Correlations between serum NO and TAC levels in the subgroups of smoking (n = 42) and non-smoking pregnant women (n = 57).
Ijerph 15 02719 g001
Ijerph 15 02719 g002 550
Figure 2. Correlations between serum NO and TOC levels in the subgroups of smoking (n = 42) and non-smoking pregnant women (n = 57).
Figure 2. Correlations between serum NO and TOC levels in the subgroups of smoking (n = 42) and non-smoking pregnant women (n = 57).
Ijerph 15 02719 g002
Ijerph 15 02719 g003 550
Figure 3. Correlations between serum NO and OSI levels in the subgroups of smoking (n = 42) and non-smoking pregnant women (n = 57).
Figure 3. Correlations between serum NO and OSI levels in the subgroups of smoking (n = 42) and non-smoking pregnant women (n = 57).
Ijerph 15 02719 g003
Ijerph 15 02719 g004 550
Figure 4. Correlations between serum eNOS and TAC levels in the subgroups of smoking (n = 42) and non-smoking pregnant women (n = 57).
Figure 4. Correlations between serum eNOS and TAC levels in the subgroups of smoking (n = 42) and non-smoking pregnant women (n = 57).
Ijerph 15 02719 g004
Ijerph 15 02719 g005 550
Figure 5. Correlations between serum eNOS and TOC levels in the subgroups of smoking (n = 42) and non-smoking pregnant women (n = 57).
Figure 5. Correlations between serum eNOS and TOC levels in the subgroups of smoking (n = 42) and non-smoking pregnant women (n = 57).
Ijerph 15 02719 g005
Table
Table 1. Literature review on the adverse effect of smoking on the progress of pregnancy and the fetus.
Table 1. Literature review on the adverse effect of smoking on the progress of pregnancy and the fetus.
NewbornReferences
Low birth weight[6]
Stillbirth[7,8]
Congenital malformation[9]
Increased risk of sudden infant death syndrome (SIDS)[10]
Behavior disorders[11]
Neurodevelopmental disorders[12]
Increased risk of overweight and obesity[13]
Increased risk of respiratory allergy[14]
Higher blood pressure[15]
Increased risk of gestational diabetes[16]
Pregnant women
Preterm premature rupture of membranes[17]
Placenta previa[18]
Ectopic pregnancy[19]
Spontaneous miscarriage[20]
Preterm birth[21,22]
Fetal growth restriction[23]
Fetal size[24]
Table
Table 2. Serum concentration of biochemical parameters in the subgroups of smoking (n = 42) and non-smoking pregnant women (n = 57).
Table 2. Serum concentration of biochemical parameters in the subgroups of smoking (n = 42) and non-smoking pregnant women (n = 57).
Biochemical ParameterSmokingNon-Smokingp Value
NO (µmol/L) a68.8 ± 15.492.1 ± 16.9≤0.001
eNOS (pg/mL) a60.4 ± 21.676.9 ± 25.50.003
iNOS (pg/mL) a101.5 ± 21.092.3 ± 19.30.020
TAC (mmol/L) a1.265 ± 0.4411.877 ± 0.483≤0.001
TOC (mmol/L) a0.417 ± 0.2100.267 ± 0.157≤0.001
OSI b42.3 (14.8–61.8)13.6 (7.2–20.1)≤0.001
Data are presented as a mean values ± standard deviation (SD), b median values and interquartile ranges (25–75th); NO—nitric oxide, eNOS—endothelial nitric oxide synthase, iNOS—inducible nitric oxide synthase, TOC—total oxidant capacity, TAC—total antioxidant capacity, OSI—oxidative stress index.
Table
Table 3. Univariable regression analyses of NO with their synthases eNOS and iNOS in the whole group of studied women (n = 99) and in the subgroups of smoking (n = 42) and non-smoking pregnant women (n = 57).
Table 3. Univariable regression analyses of NO with their synthases eNOS and iNOS in the whole group of studied women (n = 99) and in the subgroups of smoking (n = 42) and non-smoking pregnant women (n = 57).
Biochemical ParameterB95%CIβp-ValueR2
All women
eNOS0.4310.297/0.5650.543≤0.0010.295
iNOS−0.244−0.434/−0.053−0.2490.0130.062
Smokers
eNOS0.3530.155/0.5520.4940.0010.244
iNOS−0.152−0.382/0.078−0.2070.1890.043
Non-smokers
eNOS0.2940.133/0.4560.4410.0010.195
iNOS−0.099−0.335/0.138−0.1120.4070.013
NO—nitric oxide, eNOS—endothelial nitric oxide synthase, iNOS—inducible nitric oxide synthase.
Table
Table 4. Relations between studied nitric oxide parameters and oxidative stress markers in the subgroups of smoking (n = 42) and non-smoking pregnant women (n = 57).
Table 4. Relations between studied nitric oxide parameters and oxidative stress markers in the subgroups of smoking (n = 42) and non-smoking pregnant women (n = 57).
SmokingNon-Smoking
NOeNOSiNOSNOeNOSiNOS
βp-Valueβp-Valueβp-Valueβp-Valueβp-Valueβp-Value
TAC0.3270.0330.0560.994−0.1970.2110.4350.0010.3610.0060.0550.684
TOC−0.4010.008−0.3950.0100.4720.002−0.1550.250−0.1900.1580.2390.074
OSI−0.3010.053−0.2370.1310.4100.007−0.2430.069−0.2100.1170.1190.377
NO—nitric oxide, eNOS—endothelial nitric oxide synthase, iNOS—inducible nitric oxide synthase, TOC—total oxidant capacity, TAC—total antioxidant capacity, OSI—oxidative stress index.
Table
Table 5. Multivariable regression analyses (adjusted for age, gestational age, BMI) of NO with eNOS iNOS, markers of oxidative stress and smoking status in the whole group of studied women (n = 99), smoking women (n = 42), and tobacco abstinent group (n = 57).
Table 5. Multivariable regression analyses (adjusted for age, gestational age, BMI) of NO with eNOS iNOS, markers of oxidative stress and smoking status in the whole group of studied women (n = 99), smoking women (n = 42), and tobacco abstinent group (n = 57).
Biochemical ParameterB95%CIβp-Value
All women eNOS0.2680.141/0.3950.338≤0.001
iNOS−0.075−0.228/0.079−0.0760.338
TAC6.421−0.400/13.2420.1780.065
TOC−5.359−23.922/13.204−0.0520.568
Smoking status (no = 1, yes = 0)−12.299−19.340/−5.257−0.3060.001
R2 (%)54.1
Smokers
eNOS0.2750.045/0.5050.3830.021
iNOS−0.076−0.313/0.161−0.1030.519
TAC3.006−8.338/14.3500.0860.593
TOC−3.746−33.082/25.590−0.0510.797
Cotynine−0.152−0.295/−0.009−0.3230.037
R2 (%)45.2
Non-smokers
eNOS0.1940.020/0.3680.2910.030
iNOS−0.100−0.323/0.123−0.1130.373
TAC12.2822.506/22.0570.3500.015
TOC5.434−23.474/34.342−0.1640.417
R2 (%)32.7
NO—nitric oxide, eNOS—endothelial nitric oxide synthase, iNOS—inducible nitric oxide synthase, TOC—total oxidant capacity, TAC—total antioxidant capacity, OSI—oxidative stress index.

Share and Cite

MDPI and ACS Style

Chełchowska, M.; Ambroszkiewicz, J.; Gajewska, J.; Mazur, J.; Lewandowski, L.; Reśko-Zachara, M.; Maciejewski, T.M. Influence of Active Exposure to Tobacco Smoke on Nitric Oxide Status of Pregnant Women. Int. J. Environ. Res. Public Health 2018, 15, 2719. https://doi.org/10.3390/ijerph15122719

AMA Style

Chełchowska M, Ambroszkiewicz J, Gajewska J, Mazur J, Lewandowski L, Reśko-Zachara M, Maciejewski TM. Influence of Active Exposure to Tobacco Smoke on Nitric Oxide Status of Pregnant Women. International Journal of Environmental Research and Public Health. 2018; 15(12):2719. https://doi.org/10.3390/ijerph15122719

Chicago/Turabian Style

Chełchowska, Magdalena, Jadwiga Ambroszkiewicz, Joanna Gajewska, Joanna Mazur, Leszek Lewandowski, Marzanna Reśko-Zachara, and Tomasz M. Maciejewski. 2018. "Influence of Active Exposure to Tobacco Smoke on Nitric Oxide Status of Pregnant Women" International Journal of Environmental Research and Public Health 15, no. 12: 2719. https://doi.org/10.3390/ijerph15122719

APA Style

Chełchowska, M., Ambroszkiewicz, J., Gajewska, J., Mazur, J., Lewandowski, L., Reśko-Zachara, M., & Maciejewski, T. M. (2018). Influence of Active Exposure to Tobacco Smoke on Nitric Oxide Status of Pregnant Women. International Journal of Environmental Research and Public Health, 15(12), 2719. https://doi.org/10.3390/ijerph15122719

Note that from the first issue of 2016, this journal uses article numbers instead of page numbers. See further details here.

Article Metrics

Back to TopTop